National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$54.00
add to cart

Rights & Permissions

topleft topright

The Offshoring of Engineering: Facts, Unknowns, and Potential Implications (2008)

Citation Manager

. "Offshoring in the Pharmaceutical Industry--Mridula Pore, Yu Pu, Lakshman Pernenkil, and Charles L. Cooney." The Offshoring of Engineering: Facts, Unknowns, and Potential Implications. Washington, DC: The National Academies Press, 2008.

Please select a format:

BibTeX EndNote RefMan


Page
124
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


The Offshoring of Engineering: Facts, Unknowns, and Potential Implications

[31] DECHEMA (Society for Chemical Engineering and Biotechnology). 2004. Rapid growth in pharmaceuticals. Available online at http://www.dechema.de/2_Pharmaceuticals-lang-en.html.

[32] News Guangdong. 2003. New drug rule for pharmaceutical labs. Available online at http://www.newsgd.com/business/laws/200305140334.htm, accessed January 10, 2003.

[33] Dossani, R. 1999. Accessing Venture Capital in India: Report of a Conference. Asia/Pacific Research Center, Stanford University, Stanford, Calif.

[34] Advisory Committee on Venture Capital. 2003. Report of Advisory Committee on Venture Capital. Available online at http://www.sebi.gov.in/Index.jsp?contentDisp=SiteMap.

[35] IVCA (Indian Venture Capital Association). 2006. Welcome to Indian Venture Capital Association. Available online at www.indiavca.org, accessed December 3, 2006.

[36] Ernst and Young. 2005. Creating a Technology Hotbed in China: Lessons Learned From Silicon Valley and Israel. Summary Report and Suggestions to the Chinese Venture Capital Association. Available online at https://eyo-iis-pd.ey.com/drivinggrowth/unprotected/downloads/Creating_Technology_Hotbed_In_China.pdf.

[37] CVCA (Chinese Venture Capital Association). 2005. China Venture Capital Performance Report, 1994–2005. Available online at http://www.cvca.com.hk/template/reaearchtemplate.asp?ArticleID=604.

[38] The Hindu Business Line, May 25, 2006.

[39] Ravindranath, P.K. 2001. The Indian Pharmaceutical Industry since Independence. India: English Edition Publishers and Distributors Pvt Ltd.

[40] Scott, A. 2006. Indian firm secures major API contract for new drug. Chemical Week 168(18): 27.

[41] Ranbaxyusa.com, accessed September 2006.

[42] Mullin, R. 2006. Indian Firms Go Global, Chemical & Engineering News 84(39): 62–65.

[43] Jayakumar, P.B. 2006. Interview with Shen Xianji, vice director of Advisory Committee, Chinese Pharmaceutical Industry Association. PHARMABIZ.com, June 22, 2006. Available online at http://www.pharmabiz.com/article/detnews.asp?articleid=33903&sectionid=50.

[44] Coan, T., and R. Ellis. ABN AMRO, Generic Biologicals: The Next Frontier, June 2001.

[45] Schellekens, H. 2004. When biotech proteins go off-patent. Trends in Biotechnology 22(8): 406–410.

[46] Mishra, N. Credit Suisse First Boston. Equity Research, Sector Review: Indian Pharmaceuticals. October 12, 2006.

[47] ACHEMA Worldwide News. 2004. Trend Report: China’s Pharmaceutical Industry, 2004.

[48] The All India Council for Technical Education. List of accredited programs and approved institutes. Available online at http://www.aicte.ernet in 2006.

[49] Blumenthal, D., and W. Hsiao. 2005. Privatization and its discontents—the evolving Chinese health care system. New England Journal of Medicine 353 (11): 1165–1170.

[50] ICICI Lombard Insurance Direct, www.icicilombard.com, 2006.

[51] National Institute for Pharmaceutical Education and Research. www.niper.ac.in, 2006.

[52] Department of Biotechnology. 2006b. Biotechnology: A Vision (Ten Year Perspective). Department of Biotechnology, Ministry of Science & Technology, Government of India. Available online at http://dbtindia.nic.in/publication/vision/morevision.html.

[53] Department of Biotechnology. 2006c. Fact Sheet. Department of Biotechnology, Ministry of Science & Technology, Government of India. Available online at http://dbtindia.nic.in/factsheet/factsheetmain.htm.

[54] Department of Chemicals and Petrochemicals, Government of India, National Pharmaceuticals Policy, 2006, Dec 28th, 2005.

[55] Department of Biotechnology. 2006a. Annual Report 2005–2006. Department of Biotechnology, Ministry of Science & Technology, Government of India. Available online at http://dbtindia.nic.in/publication/publicmain.html.

[56] Hepeng, J. 2004. Drugmakers wrestle over medicine patents, China Business Weekly, August 17, 2004. Available online at http://www.chinadaily.com.cn/english/doc/2004-08/17/content_366249.htm.

[57] Kermani, F. 2004. Unlocking China’s Pharma Potential. Detail-Direct. com, September 24, 2004. Available online at http://www.detail-direct.com/Features/feature.asp?ROW_ID=494.

[58] World Trade Organization. www.wto.org, 2006.

[59] CCPIT Patent and Trademark Law Office. 2004. Protecting IP Rights of Pharmaceutical Manufacturers. Available online at http://www.ccpit-patent.com.cn/News/2004060301.htm.

[60] Culpepper Compensation & Benefits Surveys. 2005. Global Base Salary Increase Projections for 2006. September 13, 2005. Available online at http://www.culpepper.com/eBulletin/2005/SeptemberPayTrendsArticle.asp.

[61] Research in China. 2006. China Pharmaceutical Chain Industry Report, 2006. August 2006. Dublin, Ireland: Research and Markets.

[62] BusinessWeek Online. 2006. Readers Report: The Upside And Downside Of Outsourcing. BusinessWeek Online, February 20, 2006.

[63] Bailey, M.N., and D. Farrell. 2004. Exploding the Myths about Offshoring. April 2004. New York: McKinsey&Company. Available online at http://www.mckinsey.com/mgi/publications/myths.asp.

[64] U.S. Department of Labor. Data from Bureau of Labor Statistics. Available online at www.bls.gov.

[65] Economist Intelligence Unit. 2004. Scattering the Seeds of Invention: The Globalization of Research and Development. New York: Economist Intelligent Unit.

[66] Thursby, J., and M. Thursby. 2006. Research and development: where is the new science in corporate R&D? Science 314(5805): 1547–1548.

[67] Grace, C. 2004. The Effect of Changing Intellectual Property on Pharmaceutical Industry Prospects in India and China: Considerations for Access to Medicines. June 2004. London, U.K.: DFID Health Systems Resource Center.

[68] Lanjouw, J.O. 2005. Patents, Price Controls, and Access to New Drugs: How Policy Affects Global Market Entry. Working Paper 11321. Cambridge, Mass.: National Bureau for Economic Research.

[69] Gereffi, G., and V. Wadhwa. 2005. Framing the Engineering Outsourcing Debate: Placing the United States on a Level Playing Field with China and India. Master of Engineering Management Program, Duke University, December 2005.

[70] Fuller, D. 2006. The Fact Remains—U.S. Tech Leadership Must Be Reinforced. The Walter H. Shorenstein Asia-Pacific Research Center, Stanford University, April 7, 2006.

[71] NSF (National Science Foundation). 1998. Statistical Profiles of Foreign Doctoral Recipients in Science and Engineering: Plans to Stay in the United States. NSF 99-304. Arlington, Va.: NSF; and NSF. 1997. Science and Engineering Doctorate Awards: 1996. NSF 97-329. Arlington, Va.: NSF.

[72] NSF. 2001. Science and Engineering Doctorate Awards: 2000. Detailed Statistical Tables. NSF 02-305. Arlington, Va.: NSF.

[73] Wadhwa, V., G. Gereffi, B. Rissing, and R. Ong, 2007. Where the engineers are. Issues in Science and Technology (Spring).

[74] Gereffi, G., and V. Wadhwa. 2006. More Engineering Grads in China and India? Not so fast. Report developed by graduate students of Duke University’s Master of Engineering Management Program under the guidance of Dr. Gary Gereffi, and Vivek Wadhwa with consulting assistance from Katzenbach Partners LLC. Innovation: America’s Journal of Technology Commercialization. February/March 2006. Available online at http://www.innovation-america.org/archive.php?articleID=40.

Page
124
Front Matter (R1-R10)
Executive Summary (1-4)
Part I: Consensus Report, 1 Introduction (5-9)
2 Offshoring and Engineering: The Knowledge Base and Issues (10-19)
3 Effects of Offshoring on Specific Industries (20-32)
4 Workshop Findings and Discussion (33-41)
Additional Reading (42-44)
Part II: Commissioned Papers and Workshop Presentations, Commissioned Papers, Implications of Globalization for Software Engineering--Rafiq Dossani and Martin Kenney (45-48)
Implications of Globalization for Software Engineering--Rafiq Dossani and Martin Kenney (49-68)
The Changing Nature of Engineering in the Automotive Industry--John Moavenzadeh (69-102)
Offshoring in the Pharmaceutical Industry--Mridula Pore, Yu Pu, Lakshman Pernenkil, and Charles L. Cooney (103-124)
Impact of Globalization and Offshoring on Engineering Employment in the Personal Computing Industry--Jason Dedrick and Kenneth L. Kraemer (125-136)
Offshoring of Engineering Services in the Construction Industry--John I. Messner (137-148)
Semiconductor Engineers in a Global Economy--Clair Brown and Greg Linden (149-178)
Workshop Presentations, Implications of Offshoring for Engineering Management and Engineering Education--Anne Stevens (179-183)
An Academic Perspective on the Globalization of Engineering--Charles M. Vest (184-190)
Keynote Talk on the Globalization of Engineering--Robert Galvin (191-194)
Software-Related Offshoring--Alfred Z. Spector (195-201)
Implications of Offshoring for the Engineering Workforce and Profession--Ralph Wyndrum (202-208)
Industry Trends in Engineering Offshoring--Vivek Wadhwa (209-212)
Offshoring in the U.S. Telecommunications Industry--Theodore S. Rappaport (213-218)
Appendix A: Workshop Agenda (219-222)
Appendix B: Workshop Participants (223-228)
Appendix C: Biographical Information (229-230)